Lindiwe Faye

Person icon

Postdoctoral Research Fellow

Walter Sisulu University, South Africa

Email: lfaye@wsu.ac.za

 

 

 

 

VALIDATE Role:

Network Associate

 

Research Keywords:

TB, Antimicrobial Resistance, TB-HIV Coinfection, Clinical Trials

 

Biography:

Dr. Lindiwe Modest Faye is a dedicated medicine and health sciences researcher and academic with a PhD in Health Sciences (Medical Microbiology). Her research interests include tuberculosis, HIV, HPV, sexually transmitted infections, and antimicrobial resistance. She has extensive experience in laboratory medicine, focusing on diagnostics, clinical trials, and research. Over the past decade, Dr. Faye has made significant contributions to medical and health sciences, particularly in tuberculosis research, epidemiology, and public health in rural areas of Eastern Cape, South Africa.

She supervises postgraduate students, conducts research and lectures, and manages laboratory operations for clinical trials. Her expertise spans research design, implementation, and publication in peer-reviewed journals. Committed to advancing health knowledge, Dr. Faye mentors young scientists, fostering the development of future researchers. Her work is driven by a passion for improving healthcare outcomes, especially in resource-limited settings.

 

Key Publications:

  1. Dlatu, N.; Faye, L.M.; Apalata, T. Outcomes of Treating Tuberculosis Patients with Drug-Resistant Tuberculosis, Human Immunodeficiency Virus, and Nutritional Status: The Combined Impact of Triple Challenges in Rural Eastern Cape. Int. J. Environ. Res. Public Health 2025, 22, 319. https:// doi.org/10.3390/ijerph22030319
  2. Magwaza, C.; Laguda-Akingba,O.; Apalata,T.; Faye, L.M. Knowledge and Prevalence of Latent Tuberculosis Infection: A Feasibility and Pilot Study in a Primary Healthcare Setting in Rural Eastern Cape, South Africa. Int. J. Environ. Res. Public Health 2025, 22, 320. https://doi.org/10.3390/ ijerph22030320
  3. Faye, L.M.; Hosu, M.C.; Apalata, T. Drug-Resistant Tuberculosis Hotspots in Oliver Reginald Tambo District Municipality, Eastern Cape, South Africa. Infect. Dis. Rep. 2024, 16, 1197–1213. https:// doi.org/10.3390/idr16060095
  4. Hosu, M.C.; Faye, L.M.; Apalata, T. Comorbidities and Treatment Outcomes in Patients Diagnosed with Drug-Resistant Tuberculosis in Rural Eastern Cape Province, South Africa. Diseases 2024, 12, 296. https://doi.org/10.3390/ diseases1211029
  5. Faye, L.M.; Hosu, M.C.; Apalata, T. Drug-Resistant Tuberculosis in Rural Eastern Cape, South Africa: A Study of Patients’ Characteristics in Selected Healthcare Facilities. Int. J. Environ. Res. Public Health 2024, 21, 1594. https:// doi.org/10.3390/ijerph21121594
  6. Hosu, M.C.; Faye, L.M.; Apalata, T. Predicting Treatment Outcomes in Patients with Drug-Resistant Tuberculosis and Human Immunodeficiency Virus Coinfection, Using Supervised Machine Learning Algorithm. Pathogens 2024, 13, 923. https:// doi.org/10.3390/pathogens13110923
  7. Mbulawa, Z.Z.A.; Kondlo, S.; Toni, S.; Faye, L.M.; Businge, C.B. Prevalence, Characteristics, and Distribution of Human Papillomavirus According to Age and HIV Status in Women of Eastern Cape Province, South Africa. Viruses 2024, 16, 1751. https://doi.org/10.3390/v16111751
  8. Faye, L.M.; Hosu, M.C.; Oostvogels, S.; Dippenaar, A.; Warren, R.M.; Sineke, N.; Vasaikar, S.; Apalata, T. The Detection of Mutations and Genotyping of Drug-Resistant Mycobacterium tuberculosis Strains Isolated from Patients in the Rural Eastern Cape Province. Infect. Dis. Rep. 2023, 15, 403–416. https://doi.org/10.3390/ idr15040041
  9. Bokop, C.; Faye, L.M.; Apalata, T. Analysis of Discordance between Genotypic and Phenotypic Assays for Rifampicin-Resistant Mycobacterium tuberculosis Isolated from Healthcare Facilities in Mthatha. Pathogens 2023, 12, 909. https://doi.org/10.3390/ pathogens12070909
  10. Faye, L.M.; Hosu, M.C.; Iruedo, J.; Vasaikar, S.; Nokoyo, K.A.; Tsuro, U.; Apalata, T. Treatment Outcomes and Associated Factors among Tuberculosis Patients from Selected Rural Eastern Cape Hospitals: An Ambidirectional Study. Trop. Med. Infect. Dis. 2023, 8, 315. https://doi.org/10.3390/ tropicalmed8060315